Core Viewpoint - Doximity reported quarterly earnings of $0.30 per share, exceeding the Zacks Consensus Estimate of $0.26 per share, and showing an increase from $0.22 per share a year ago, indicating a 15.38% earnings surprise [1] Financial Performance - Doximity's revenues for the quarter ended September 2024 were $136.83 million, surpassing the Zacks Consensus Estimate by 7.70% and up from $113.61 million year-over-year [2] - The company has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Stock Performance - Doximity shares have increased approximately 51% since the beginning of the year, compared to a 24.3% gain in the S&P 500 [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.28 on revenues of $140.06 million, and for the current fiscal year, it is $1.05 on revenues of $520.23 million [7] - The outlook for the Medical Services industry, where Doximity operates, is currently in the bottom 45% of Zacks industries, which may impact stock performance [8]
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates